Niche heterogeneity in the bone marrow

Annals of the New York Academy of Sciences

Volumn 1370, Issue 1, 2016, Pages 82-96

  Birbrair, Alexander ^a   Frenette, Paul S ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

BM; microenvironment; niche; stem cells

Indexed keywords

ADIPOCYTE; BONE MARROW; CELL HETEROGENEITY; ENDOTHELIUM CELL; HEMATOPOIETIC STEM CELL; HUMAN; LYMPHOCYTE; MACROPHAGE; MEGAKARYOCYTE; NERVE; NEUTROPHIL; OSTEOBLAST; OSTEOCLAST; REVIEW; SCHWANN CELL;

EID: 84976635421     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/nyas.13016     Document Type: Review

References (219)

1. Pang, W.W. et al. 2011. Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age. Proc. Natl. Acad. Sci. U.S.A. 108: 20012–20017.
2. Oguro, H., L. Ding & S.J. Morrison. 2013. SLAM family markers resolve functionally distinct subpopulations of hematopoietic stem cells and multipotent progenitors. Cell Stem Cell 13: 102–116.
3. Gazit, R., I.L. Weissman & D.J. Rossi. 2008. Hematopoietic stem cells and the aging hematopoietic system. Semin. Hematol. 45: 218–224.
4. Seita, J. & I.L. Weissman. 2010. Hematopoietic stem cell: self-renewal versus differentiation. Wiley Interdiscip. Rev. Syst. Biol. Med. 2: 640–653.
5. Zon, L.I. 2008. Intrinsic and extrinsic control of haematopoietic stem-cell self-renewal. Nature 453: 306–313.
6. Laurenti, E. & J.E. Dick. 2012. Molecular and functional characterization of early human hematopoiesis. Ann. N.Y. Acad. Sci. 1266: 68–71.
7. Benveniste, P. et al. 2003. Hematopoietic stem cells engraft in mice with absolute efficiency. Nat. Immunol. 4: 708–713.
8. Frelin, C. et al. 2013. GATA-3 regulates the self-renewal of long-term hematopoietic stem cells. Nat. Immunol. 14: 1037–1044.
9. Till, J.E. & C.E. McCulloch. 1961. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat. Res. 14: 213–222.
10. Mirantes, C., E. Passegue & E.M. Pietras. 2014. Pro-inflammatory cytokines: emerging players regulating HSC function in normal and diseased hematopoiesis. Exp. Cell Res. 329: 248–254.
11. Thomas, E.D. et al. 1957. Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N. Engl. J. Med. 257: 491–496.
12. Morrison, S.J. & D.T. Scadden. 2014. The bone marrow niche for haematopoietic stem cells. Nature 505: 327–334.
13. Mendelson, A. & P.S. Frenette. 2014. Hematopoietic stem cell niche maintenance during homeostasis and regeneration. Nat. Med. 20: 833–846.
14. Schofield, R. 1978. The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells 4: 7–25.
15. Rashidi, N.M. et al. 2014. In vivo time-lapse imaging shows diverse niche engagement by quiescent and naturally activated hematopoietic stem cells. Blood 124: 79–83.
16. Orkin, S.H. & L.I. Zon. 2008. Hematopoiesis: an evolving paradigm for stem cell biology. Cell 132: 631–644.
17. Guenechea, G. et al. 2001. Distinct classes of human stem cells that differ in proliferative and self-renewal potential. Nat. Immunol. 2: 75–82.
18. Ema, H. et al. 2005. Quantification of self-renewal capacity in single hematopoietic stem cells from normal and Lnk-deficient mice. Dev. Cell 8: 907–914.
19. Osawa, M. et al. 1996. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 273: 242–245.
20. Morrison, S.J. et al. 1997. Identification of a lineage of multipotent hematopoietic progenitors. Development 124: 1929–1939.
21. − short-term hematopoietic stem cells capable of rapidly reconstituting and rescuing myeloablated transplant recipients. Blood 105: 2717–2723.
22. Muller-Sieburg, C.E. et al. 2012. Stem cell heterogeneity: implications for aging and regenerative medicine. Blood 119: 3900–3907.
23. Yamamoto, R. et al. 2013. Clonal analysis unveils self-renewing lineage-restricted progenitors generated directly from hematopoietic stem cells. Cell 154: 1112–1126.
24. Purton, L.E. & D.T. Scadden. 2007. Limiting factors in murine hematopoietic stem cell assays. Cell Stem Cell 1: 263–270.
25. Kiel, M.J. et al. 2005. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121: 1109–1121.
26. Kent, D.G. et al. 2009. Prospective isolation and molecular characterization of hematopoietic stem cells with durable self-renewal potential. Blood 113: 6342–6350.
27. Benveniste, P. et al. 2010. Intermediate-term hematopoietic stem cells with extended but time-limited reconstitution potential. Cell Stem Cell 6: 48–58.
28. Gekas, C. & T. Graf. 2013. CD41 expression marks myeloid-biased adult hematopoietic stem cells and increases with age. Blood 121: 4463–4472.
29. Muller-Sieburg, C.E. et al. 2004. Myeloid-biased hematopoietic stem cells have extensive self-renewal capacity but generate diminished lymphoid progeny with impaired IL-7 responsiveness. Blood 103: 4111–4118.
30. Dykstra, B. et al. 2007. Long-term propagation of distinct hematopoietic differentiation programs in vivo. Cell Stem Cell 1: 218–229.
31. Benz, C. et al. 2012. Hematopoietic stem cell subtypes expand differentially during development and display distinct lymphopoietic programs. Cell Stem Cell 10: 273–283.
32. Challen, G.A. et al. 2010. Distinct hematopoietic stem cell subtypes are differentially regulated by TGF-β1. Cell Stem Cell 6: 265–278.
33. Sanjuan-Pla, A. et al. 2013. Platelet-biased stem cells reside at the apex of the haematopoietic stem-cell hierarchy. Nature 502: 232–236.
34. Copley, M.R., P.A. Beer & C.J. Eaves. 2012. Hematopoietic stem cell heterogeneity takes center stage. Cell Stem Cell 10: 690–697.
35. Eaves, C.J. 2015. Hematopoietic stem cells: concepts, definitions, and the new reality. Blood 125: 2605–2613.
36. Ema, H., Y. Morita & T. Suda. 2014. Heterogeneity and hierarchy of hematopoietic stem cells. Exp. Hematol. 42: 74–82.e2.
37. Ellis, S.L. et al. 2011. The relationship between bone, hemopoietic stem cells, and vasculature. Blood 118: 1516–1524.
38. Nombela-Arrieta, C. et al. 2013. Quantitative imaging of haematopoietic stem and progenitor cell localization and hypoxic status in the bone marrow microenvironment. Nat. Cell Biol. 15: 533–543.
39. Adams, G.B. et al. 2006. Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor. Nature 439: 599–603.
40. Guezguez, B. et al. 2013. Regional localization within the bone marrow influences the functional capacity of human HSCs. Cell Stem Cell 13: 175–189.
41. Kunisaki, Y. et al. 2013. Arteriolar niches maintain haematopoietic stem cell quiescence. Nature 502: 637–643.
42. Haylock, D.N. et al. 2007. Hemopoietic stem cells with higher hemopoietic potential reside at the bone marrow endosteum. Stem Cells 25: 1062–1069.
43. Acar, M. et al. 2015. Deep imaging of bone marrow shows non-dividing stem cells are mainly perisinusoidal. Nature 526: 126–130.
44. Kohler, A. et al. 2009. Altered cellular dynamics and endosteal location of aged early hematopoietic progenitor cells revealed by time-lapse intravital imaging in long bones. Blood 114: 290–298.
45. De Bruyn, P.P., P.C. Breen & T.B. Thomas. 1970. The microcirculation of the bone marrow. Anat. Rec. 168: 55–68.
46. Munka, V. & A. Gregor. 1965. Lymphatics and bone marrow. Folia Morphol. (Praha) 13: 404–412.
47. Nees, S. et al. 2012. Wall structures of myocardial precapillary arterioles and postcapillary venules reexamined and reconstructed in vitro for studies on barrier functions. Am. J. Physiol. Heart Circ. Physiol. 302: H51–H68.
48. Walmsley, J.G. et al. 1982. Quantitative morphology of arterioles from the hamster cheek pouch related to mechanical analysis. Microvasc. Res. 24: 249–271.
49. Katayama, Y. et al. 2006. Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell 124: 407–421.
50. Sugiyama, T. et al. 2006. Maintenance of the hematopoietic stem cell pool by CXCL12–CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 25: 977–988.
51. Weiss, L. & U. Geduldig. 1991. Barrier cells: stromal regulation of hematopoiesis and blood cell release in normal and stressed murine bone marrow. Blood 78: 975–990.
52. Socolovsky, M. 2013. Exploring the erythroblastic island. Nat. Med. 19: 399–401.
53. Ramos, P. et al. 2013. Macrophages support pathological erythropoiesis in polycythemia vera and β-thalassemia. Nat. Med. 19: 437–445.
54. + macrophages provide a niche promoting erythropoiesis under homeostasis and stress. Nat. Med. 19: 429–436.
55. Bruns, I. et al. 2014. Megakaryocytes regulate hematopoietic stem cell quiescence through CXCL4 secretion. Nat. Med. 20: 1315–1320.
56. Zhao, M. et al. 2014. Megakaryocytes maintain homeostatic quiescence and promote post-injury regeneration of hematopoietic stem cells. Nat. Med. 20: 1321–1326.
57. Rhodes, K.E. et al. 2008. The emergence of hematopoietic stem cells is initiated in the placental vasculature in the absence of circulation. Cell Stem Cell 2: 252–263.
58. Khan, J.A. et al. 2016. Fetal liver hematopoietic stem cell niches associate with portal vessels. Science 351: 176–180.
59. Taichman, R.S. & S.G. Emerson. 1998. The role of osteoblasts in the hematopoietic microenvironment. Stem Cells 16: 7–15.
60. Taichman, R.S., M.J. Reilly & S.G. Emerson. 2000. The hematopoietic microenvironment: osteoblasts and the hematopoietic microenvironment. Hematology 4: 421–426.
61. El-Badri, N.S. et al. 1998. Osteoblasts promote engraftment of allogeneic hematopoietic stem cells. Exp. Hematol. 26: 110–116.
62. Taichman, R.S. & S.G. Emerson. 1994. Human osteoblasts support hematopoiesis through the production of granulocyte colony-stimulating factor. J. Exp. Med. 179: 1677–1682.
63. Nilsson, S.K. et al. 2005. Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells. Blood 106: 1232–1239.
64. Stier, S. et al. 2005. Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size. J. Exp. Med. 201: 1781–1791.
65. Arai, F. et al. 2004. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 118: 149–161.
66. Calvi, L.M. et al. 2003. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425: 841–846.
67. Visnjic, D. et al. 2004. Hematopoiesis is severely altered in mice with an induced osteoblast deficiency. Blood 103: 3258–3264.
68. Mizoguchi, T. et al. 2014. Osterix marks distinct waves of primitive and definitive stromal progenitors during bone marrow development. Dev. Cell 29: 340–349.
69. Omatsu, Y. et al. 2010. The essential functions of adipo-osteogenic progenitors as the hematopoietic stem and progenitor cell niche. Immunity 33: 387–399.
70. Mendez-Ferrer, S. et al. 2010. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466: 829–834.
71. Lymperi, S. et al. 2008. Strontium can increase some osteoblasts without increasing hematopoietic stem cells. Blood 111: 1173–1181.
72. Marie, P.J. 2005. Strontium as therapy for osteoporosis. Curr. Opin. Pharmacol. 5: 633–636.
73. Calvi, L.M. et al. 2012. Osteoblastic expansion induced by parathyroid hormone receptor signaling in murine osteocytes is not sufficient to increase hematopoietic stem cells. Blood 119: 2489–2499.
74. Zhu, J. et al. 2007. Osteoblasts support B-lymphocyte commitment and differentiation from hematopoietic stem cells. Blood 109: 3706–3712.
75. Bowers, M. et al. 2015. Osteoblast ablation reduces normal long-term hematopoietic stem cell self-renewal but accelerates leukemia development. Blood 125: 2678–2688.
76. Ding, L. & S.J. Morrison. 2013. Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches. Nature 495: 231–235.
77. Ribatti, D. et al. 2002. Endothelial cell heterogeneity and organ specificity. J. Hematother. Stem Cell Res. 11: 81–90.
78. Kiel, M.J. et al. 2005. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121: 1109–1121.
79. Hooper, A.T. et al. 2009. Engraftment and reconstitution of hematopoiesis is dependent on VEGFR2-mediated regeneration of sinusoidal endothelial cells. Cell Stem Cell 4: 263–274.
80. Kobayashi, H. et al. 2010. Angiocrine factors from Akt-activated endothelial cells balance self-renewal and differentiation of haematopoietic stem cells. Nat. Cell Biol. 12: 1046–1056.
81. Salter, A.B. et al. 2009. Endothelial progenitor cell infusion induces hematopoietic stem cell reconstitution in vivo. Blood 113: 2104–2107.
82. Butler, J.M. et al. 2010. Endothelial cells are essential for the self-renewal and repopulation of Notch-dependent hematopoietic stem cells. Cell Stem Cell 6: 251–264.
83. + PBPC through IL-6 secretion. Cytotherapy 8: 335–342.
84. + hematopoietic progenitor cells in coculture with autologous umbilical vein endothelial cells (HUVEC) is superior to cytokine-supplemented liquid culture. Bone Marrow Transplant. 36: 71–79.
85. Chute, J.P. et al. 2002. Ex vivo culture with human brain endothelial cells increases the SCID-repopulating capacity of adult human bone marrow. Blood 100: 4433–4439.
86. − cells and SCID-repopulating cells. Blood 105: 576–583.
87. Li, B. et al. 2010. Endothelial cells mediate the regeneration of hematopoietic stem cells. Stem Cell Res. 4: 17–24.
88. Himburg, H.A. et al. 2010. Pleiotrophin regulates the expansion and regeneration of hematopoietic stem cells. Nat. Med. 16: 475–482.
89. Doan, P.L. et al. 2013. Epidermal growth factor regulates hematopoietic regeneration after radiation injury. Nat. Med. 19: 295–304.
90. Zhou, B.O., L. Ding & S.J. Morrison. 2015. Hematopoietic stem and progenitor cells regulate the regeneration of their niche by secreting angiopoietin-1. EeLife 4: e05521.
91. Li, W. et al. 2003. Primary endothelial cells isolated from the yolk sac and para-aortic splanchnopleura support the expansion of adult marrow stem cells in vitro. Blood 102: 4345–4353.
92. Ohneda, O. et al. 1998. Hematopoietic stem cell maintenance and differentiation are supported by embryonic aorta-gonad-mesonephros region-derived endothelium. Blood 92: 908–919.
93. Li, W. et al. 2004. Hematopoietic stem cell repopulating ability can be maintained in vitro by some primary endothelial cells. Exp. Hematol. 32: 1226–1237.
94. Yao, L. et al. 2005. Bone marrow dysfunction in mice lacking the cytokine receptor gp130 in endothelial cells. Blood 106: 4093–4101.
95. Ding, L. et al. 2012. Endothelial and perivascular cells maintain haematopoietic stem cells. Nature 481: 457–462.
96. Greenbaum, A. et al. 2013. CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance. Nature 495: 227–230.
97. Aird, W.C. 2007. Phenotypic heterogeneity of the endothelium: II. Representative vascular beds. Circ. Res. 100: 174–190.
98. Aird, W.C. 2007. Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ. Res. 100: 158–173.
99. Birbrair, A. & O. Delbono. 2015. Pericytes are essential for skeletal muscle formation. Stem Cell Rev. 11: 547–548.
100. Birbrair, A. et al. 2014. Type-1 pericytes accumulate after tissue injury and produce collagen in an organ-dependent manner. Stem Cell Res. Ther. 5: 122.
101. Birbrair, A. et al. 2015. Pericytes at the intersection between tissue regeneration and pathology. Clin. Sci. (Lond.) 128: 81–93.
102. Birbrair, A. et al. 2014. Type-2 pericytes participate in normal and tumoral angiogenesis. Am. J. Physiol. Cell Physiol. 307: C25–C38.
103. Birbrair, A. et al. 2013. Role of pericytes in skeletal muscle regeneration and fat accumulation. Stem Cells Dev. 22: 2298–2314.
104. Birbrair, A. et al. 2013. Type-1 pericytes participate in fibrous tissue deposition in aged skeletal muscle. Am. J. Physiol. Cell Physiol. 305: C1098–C1113.
105. Birbrair, A. et al. 2013. Skeletal muscle pericyte subtypes differ in their differentiation potential. Stem Cell Res. 10: 67–84.
106. Birbrair, A. et al. 2014. Pericytes: multitasking cells in the regeneration of injured, diseased, and aged skeletal muscle. Front. Aging Neurosci. 6: 245.
107. Sacchetti, B. et al. 2007. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131: 324–336.
108. + sphere-forming mesenchymal stem cells capable of hematopoietic progenitor cell expansion. J. Exp. Med. 210: 1351–1367.
109. Omatsu, Y. et al. 2014. Foxc1 is a critical regulator of haematopoietic stem/progenitor cell niche formation. Nature 508: 536–540.
110. Morikawa, S. et al. 2009. Development of mesenchymal stem cells partially originate from the neural crest. Biochem. Biophys. Res. Commun. 379: 1114–1119.
111. Morikawa, S. et al. 2009. Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow. J. Exp. Med. 206: 2483–2496.
112. Kopp, H.G. et al. 2005. The bone marrow vascular niche: home of HSC differentiation and mobilization. Physiology 20: 349–356.
113. Gimble, J.M. & M.E. Nuttall. 2004. Bone and fat: old questions, new insights. Endocrine 23: 183–188.
114. Krings, A. et al. 2012. Bone marrow fat has brown adipose tissue characteristics, which are attenuated with aging and diabetes. Bone 50: 546–552.
115. Fazeli, P.K. et al. 2013. Marrow fat and bone—new perspectives. J. Clin. Endocrinol. Metab. 98: 935–945.
116. Abella, E. et al. 2002. Bone marrow changes in anorexia nervosa are correlated with the amount of weight loss and not with other clinical findings. Am. J. Clin. Pathol. 118: 582–588.
117. Cohen, A. et al. 2012. Increased marrow adiposity in premenopausal women with idiopathic osteoporosis. J. Clin. Endocrinol. Metab. 97: 2782–2791.
118. Gimble, J.M. 1990. The function of adipocytes in the bone marrow stroma. New Biol. 2: 304–312.
119. Kawai, M., F.J. de Paula & C.J. Rosen. 2012. New insights into osteoporosis: the bone–fat connection. J. Intern. Med. 272: 317–329.
120. Poloni, A. et al. 2013. Molecular and functional characterization of human bone marrow adipocytes. Exp. Hematol. 41: 558–566.e2.
121. Liu, L.F. et al. 2011. Characterization of age-related gene expression profiling in bone marrow and epididymal adipocytes. BMC Genomics 12: 212.
122. Devlin, M.J. et al. 2010. Caloric restriction leads to high marrow adiposity and low bone mass in growing mice. J. Bone Miner. Res. 25: 2078–2088.
123. Griffith, J.F. et al. 2012. Bone marrow fat content in the elderly: a reversal of sex difference seen in younger subjects. J. Magn. Reson. Imaging 36: 225–230.
124. Rosen, C.J. et al. 2009. Marrow fat and the bone microenvironment: developmental, functional, and pathological implications. Crit. Rev. Eukaryot. Gene Expr. 19: 109–124.
125. Lecka-Czernik, B., C.J. Rosen & M. Kawai. 2010. Skeletal aging and the adipocyte program: new insights from an “old” molecule. Cell Cycle 9: 3648–3654.
126. Ogawa, T., M. Kitagawa & K. Hirokawa. 2000. Age-related changes of human bone marrow: a histometric estimation of proliferative cells, apoptotic cells, T cells, B cells and macrophages. Mech. Ageing Dev. 117: 57–68.
127. Cao, J.J., L. Sun & H. Gao. 2010. Diet-induced obesity alters bone remodeling leading to decreased femoral trabecular bone mass in mice. Ann. N.Y. Acad. Sci. 1192: 292–297.
128. Halade, G.V. et al. 2010. High fat diet-induced animal model of age-associated obesity and osteoporosis. J. Nutr. Biochem. 21: 1162–1169.
129. Halade, G.V. et al. 2011. Obesity-mediated inflammatory microenvironment stimulates osteoclastogenesis and bone loss in mice. Exp. Gerontol. 46: 43–52.
130. Trottier, M.D. et al. 2012. Enhancement of hematopoiesis and lymphopoiesis in diet-induced obese mice. Proc. Natl. Acad. Sci. U.S.A. 109: 7622–7629.
131. Laharrague, P. et al. 2000. Inflammatory/haematopoietic cytokine production by human bone marrow adipocytes. Eur. Cytokine Netw. 11: 634–639.
132. Claycombe, K., L.E. King & P.J. Fraker. 2008. A role for leptin in sustaining lymphopoiesis and myelopoiesis. Proc. Natl. Acad. Sci. U. S. A. 105: 2017–2021.
133. Chitteti, B.R. et al. 2010. Impact of interactions of cellular components of the bone marrow microenvironment on hematopoietic stem and progenitor cell function. Blood 115: 3239–3248.
134. Spindler, T.J. et al. 2014. Adipocytic cells augment the support of primitive hematopoietic cells in vitro but have no effect in the bone marrow niche under homeostatic conditions. Stem Cells Dev. 23: 434–441.
135. Corre, J. et al. 2004. Human bone marrow adipocytes support complete myeloid and lymphoid differentiation from human CD34 cells. Br. J. Haematol. 127: 344–347.
136. Naveiras, O. et al. 2009. Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment. Nature 460: 259–263.
137. Yokota, T. et al. 2000. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 96: 1723–1732.
138. Touw, I. & B. Lowenberg. 1983. No stimulative effect of adipocytes on hematopoiesis in long-term human bone marrow cultures. Blood 61: 770–774.
139. Gimble, J.M. & M.E. Nuttall. 2012. The relationship between adipose tissue and bone metabolism. Clin. Biochem. 45: 874–879.
140. Lecka-Czernik, B. 2012. Marrow fat metabolism is linked to the systemic energy metabolism. Bone 50: 534–539.
141. Zhu, R.J. et al. 2013. Hematopoietic recovery following chemotherapy is improved by BADGE-induced inhibition of adipogenesis. Int. J. Hematol. 97: 58–72.
142. Belaid-Choucair, Z. et al. 2008. Human bone marrow adipocytes block granulopoiesis through neuropilin-1-induced granulocyte colony-stimulating factor inhibition. Stem Cells 26: 1556–1564.
143. Miharada, K. et al. 2008. Lipocalin 2-mediated growth suppression is evident in human erythroid and monocyte/macrophage lineage cells. J. Cell. Physiol. 215: 526–537.
144. DiMascio, L. et al. 2007. Identification of adiponectin as a novel hemopoietic stem cell growth factor. J. Immunol. 178: 3511–3520.
145. Hotamisligil, G.S., N.S. Shargill & B.M. Spiegelman. 1993. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259: 87–91.
146. Calvo, W. & J. Forteza-Vila. 1970. Schwann cells of the bone marrow. Blood 36: 180–188.
147. Castaneda-Corral, G. et al. 2011. The majority of myelinated and unmyelinated sensory nerve fibers that innervate bone express the tropomyosin receptor kinase A. Neuroscience 178: 196–207.
148. Son, Y.J. & W.J. Thompson. 1995. Schwann cell processes guide regeneration of peripheral axons. Neuron 14: 125–132.
149. Hoke, A. 2006. Mechanisms of disease: what factors limit the success of peripheral nerve regeneration in humans? Nat. Clin. Pract. Neurol. 2: 448–454.
150. Gordon, T. 2014. Neurotrophic factor expression in denervated motor and sensory Schwann cells: relevance to specificity of peripheral nerve regeneration. Exp. Neurol. 254: 99–108.
151. Ozaki, A. et al. 2008. Expression of cytokines and cytokine receptors in human Schwann cells. Neuroreport 19: 31–35.
152. Yamazaki, S. et al. 2011. Nonmyelinating Schwann cells maintain hematopoietic stem cell hibernation in the bone marrow niche. Cell 147: 1146–1158.
153. Mendez-Ferrer, S. et al. 2008. Haematopoietic stem cell release is regulated by circadian oscillations. Nature 452: 442–447.
154. Ciurea, S.O. et al. 2007. Pivotal contributions of megakaryocytes to the biology of idiopathic myelofibrosis. Blood 110: 986–993.
155. Yamazaki, K. & T.D. Allen. 1990. Ultrastructural morphometric study of efferent nerve terminals on murine bone marrow stromal cells, and the recognition of a novel anatomical unit: the “neuro-reticular complex.” Am. J. Anat. 187: 261–276.
156. Zhou, B.O. et al. 2014. Leptin-receptor-expressing mesenchymal stromal cells represent the main source of bone formed by adult bone marrow. Cell Stem Cell 15: 154–168.
157. Hanoun, M. et al. 2015. Neural regulation of hematopoiesis, inflammation, and cancer. Neuron 86: 360–373.
158. Boulais, P.E. & P.S. Frenette. 2015. Making sense of hematopoietic stem cell niches. Blood 125: 2621–2629.
159. + cells by the nervous system. Brain Behav. Immun. 23: 1059–1065.
160. Afan, A.M. et al. 1997. Bone marrow innervation regulates cellular retention in the murine haemopoietic system. Br. J. Haematol. 98: 569–577.
161. Lucas, D. et al. 2013. Chemotherapy-induced bone marrow nerve injury impairs hematopoietic regeneration. Nat. Med. 19: 695–703.
162. Scheiermann, C. et al. 2012. Adrenergic nerves govern circadian leukocyte recruitment to tissues. Immunity 37: 290–301.
163. Scheiermann, C., Y. Kunisaki & P.S. Frenette. 2013. Circadian control of the immune system. Nat. Rev. Immunol. 13: 190–198.
164. Haus, E. et al. 1983. Chronobiology in hematology and immunology. Am. J. Anat. 168: 467–517.
165. Haus, E. & M.H. Smolensky. 1999. Biologic rhythms in the immune system. Chronobiol. Int. 16: 581–622.
166. Lucas, D. et al. 2008. Mobilized hematopoietic stem cell yield depends on species-specific circadian timing. Cell Stem Cell 3: 364–366.
167. Hanoun, M. et al. 2014. Acute myelogenous leukemia-induced sympathetic neuropathy promotes malignancy in an altered hematopoietic stem cell niche. Cell Stem Cell 15: 365–375.
168. Arranz, L. et al. 2014. Neuropathy of haematopoietic stem cell niche is essential for myeloproliferative neoplasms. Nature 512: 78–81.
169. + cells through Wnt signaling. Nat. Immunol. 8: 1123–1131.
170. Fitch, S.R. et al. 2012. Signaling from the sympathetic nervous system regulates hematopoietic stem cell emergence during embryogenesis. Cell Stem Cell 11: 554–566.
171. Alexander, K.A. et al. 2011. Osteal macrophages promote in vivo intramembranous bone healing in a mouse tibial injury model. J. Bone Miner. Res. 26: 1517–1532.
172. Chang, M.K. et al. 2008. Osteal tissue macrophages are intercalated throughout human and mouse bone lining tissues and regulate osteoblast function in vitro and in vivo. J. Immunol. 181: 1232–1244.
173. Pettit, A.R. et al. 2008. Osteal macrophages: a new twist on coupling during bone dynamics. Bone 43: 976–982.
174. Winkler, I.G. et al. 2010. Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCs. Blood 116: 4815–4828.
175. + macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche. J. Exp. Med. 208: 261–271.
176. Christopher, M.J. et al. 2011. Expression of the G-CSF receptor in monocytic cells is sufficient to mediate hematopoietic progenitor mobilization by G-CSF in mice. J. Exp. Med. 208: 251–260.
177. Albiero, M. et al. 2015. Bone marrow macrophages contribute to diabetic stem cell mobilopathy by producing oncostatin M. Diabetes 64: 2957–2968.
178. Williams, D.A. et al. 1991. Fibronectin and VLA-4 in haematopoietic stem cell–microenvironment interactions. Nature 352: 438–441.
179. Scott, L.M., G.V. Priestley & T. Papayannopoulou. 2003. Deletion of α4 integrins from adult hematopoietic cells reveals roles in homeostasis, regeneration, and homing. Mol. Cell. Biol. 23: 9349–9360.
180. Dutta, P. et al. 2012. Myocardial infarction accelerates atherosclerosis. Nature 487: 325–329.
181. Dutta, P. et al. 2015. Macrophages retain hematopoietic stem cells in the spleen via VCAM-1. J. Exp. Med. 212: 497–512.
182. Ludin, A. et al. 2012. Monocytes–macrophages that express α-smooth muscle actin preserve primitive hematopoietic cells in the bone marrow. Nat. Immunol. 13: 1072–1082.
183. Hoggatt, J. et al. 2009. Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation. Blood 113: 5444–5455.
184. Casanova-Acebes, M. et al. 2013. Rhythmic modulation of the hematopoietic niche through neutrophil clearance. Cell 153: 1025–1035.
185. Wheway, J. et al. 2005. A fundamental bimodal role for neuropeptide Y1 receptor in the immune system. J. Exp. Med. 202: 1527–1538.
186. Kuo, L.E. et al. 2007. Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Nat. Med. 13: 803–811.
187. Lee, N.J. & H. Herzog. 2009. NPY regulation of bone remodelling. Neuropeptides 43: 457–463.
188. Park, M.H. et al. 2015. Neuropeptide Y regulates the hematopoietic stem cell microenvironment and prevents nerve injury in the bone marrow. EMBO J. 34: 1648–1660.
189. Manwani, D. & J.J. Bieker. 2008. The erythroblastic island. Curr. Top. Dev. Biol. 82: 23–53.
190. Boyle, W.J., W.S. Simonet & D.L. Lacey. 2003. Osteoclast differentiation and activation. Nature 423: 337–342.
191. Kollet, O. et al. 2006. Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nat. Med. 12: 657–664.
192. Balooch, G. et al. 2005. TGF-β regulates the mechanical properties and composition of bone matrix. Proc. Natl. Acad. Sci. U.S.A. 102: 18813–18818.
193. Lymperi, S. et al. 2011. Inhibition of osteoclast function reduces hematopoietic stem cell numbers in vivo. Blood 117: 1540–1549.
194. Mansour, A. et al. 2012. Osteoclasts promote the formation of hematopoietic stem cell niches in the bone marrow. J. Exp. Med. 209: 537–549.
195. Nakamura-Ishizu, A. et al. 2014. Megakaryocytes are essential for HSC quiescence through the production of thrombopoietin. Biochem. Biophys. Res. Commun. 454: 353–357.
196. Heazlewood, S.Y. et al. 2013. Megakaryocytes co-localise with hemopoietic stem cells and release cytokines that up-regulate stem cell proliferation. Stem Cell Res. 11: 782–792.
197. Kacena, M.A., C.M. Gundberg & M.C. Horowitz. 2006. A reciprocal regulatory interaction between megakaryocytes, bone cells, and hematopoietic stem cells. Bone 39: 978–984.
198. Olson, T.S. et al. 2013. Megakaryocytes promote murine osteoblastic HSC niche expansion and stem cell engraftment after radioablative conditioning. Blood 121: 5238–5249.
199. Soderberg, S.S., G. Karlsson & S. Karlsson. 2009. Complex and context dependent regulation of hematopoiesis by TGF-β superfamily signaling. Ann. N.Y. Acad. Sci. 1176: 55–69.
200. Mercier, F.E., C. Ragu & D.T. Scadden. 2012. The bone marrow at the crossroads of blood and immunity. Nat. Rev. Immunol. 12: 49–60.
201. Barlozzari, T., R.B. Herberman & C.W. Reynolds. 1987. Inhibition of pluripotent hematopoietic stem cells of bone marrow by large granular lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 84: 7691–7695.
202. Degliantoni, G. et al. 1985. Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor. Relationship with tumor necrosis factor and synergism with immune interferon. J. Exp. Med. 162: 1512–1530.
203. Sharara, L.I. et al. 1997. Deregulated TCR alpha beta T cell population provokes extramedullary hematopoiesis in mice deficient in the common gamma chain. Eur. J. Immunol. 27: 990–998.
204. + T cells. Blood 105: 1484–1491.
205. Zeng, D. et al. 2002. Unique patterns of surface receptors, cytokine secretion, and immune functions distinguish T cells in the bone marrow from those in the periphery: impact on allogeneic bone marrow transplantation. Blood 99: 1449–1457.
206. + T cells in mouse bone marrow. I. Increased activated/memory phenotype and altered TCR Vbeta repertoire. Eur. J. Immunol. 29: 1051–1056.
207. + T cells. Blood 115: 4934–4943.
208. reg cells providing immune privilege to the haematopoietic stem-cell niche. Nature 474: 216–219.
209. Summers, C. et al. 2010. Neutrophil kinetics in health and disease. Trends Immunol. 31: 318–324.
210. Furze, R.C. & S.M. Rankin. 2008. Neutrophil mobilization and clearance in the bone marrow. Immunology 125: 281–288.
211. Petit, I. et al. 2002. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat. Immunol. 3: 687–694.
212. Valenzuela-Fernandez, A. et al. 2002. Leukocyte elastase negatively regulates stromal cell-derived factor-1 (SDF-1)/CXCR4 binding and functions by amino-terminal processing of SDF-1 and CXCR4. J. Biol. Chem. 277: 15677–15689.
213. Levesque, J.P. et al. 2001. Vascular cell adhesion molecule-1 (CD106) is cleaved by neutrophil proteases in the bone marrow following hematopoietic progenitor cell mobilization by granulocyte colony-stimulating factor. Blood 98: 1289–1297.
214. Levesque, J.P. et al. 2003. Granulocyte colony-stimulating factor induces the release in the bone marrow of proteases that cleave c-KIT receptor (CD117) from the surface of hematopoietic progenitor cells. Exp. Hematol. 31: 109–117.
215. Heissig, B. et al. 2002. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 109: 625–637.
216. Levesque, J.P. et al. 2004. Characterization of hematopoietic progenitor mobilization in protease-deficient mice. Blood 104: 65–72.
217. Singh, P. et al. 2012. Expansion of bone marrow neutrophils following G-CSF administration in mice results in osteolineage cell apoptosis and mobilization of hematopoietic stem and progenitor cells. Leukemia 26: 2375–2383.
218. Eash, K.J. et al. 2009. CXCR4 is a key regulator of neutrophil release from the bone marrow under basal and stress granulopoiesis conditions. Blood 113: 4711–4719.
219. Poulos, M.G. et al. 2013. Endothelial Jagged-1 is necessary for homeostatic and regenerative hematopoiesis. Cell Rep. 4: 1022–1034.